Stacy L. Taylor, SVP and General Counsel at Adaptive Biotechnologies Corp (ADPT), sold 26,922 shares at $4.50 ($121K) on 2024-08-22, disclosed to the SEC on 2024-08-23.
Scheduled sale ($121k) by SVP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2022-03-10 | $27K | — | Filing → |
| ADPT | SELL | 2022-03-08 | $19K | — | Filing → |
| ADPT | SELL | 2021-12-23 | $460K | — | Filing → |